MEDI ETF holdings (NYSE) | MetaTrader

전체 차트 열기 Full chart

개요 모든 보유 자산 히트맵

주요 보유 종목 Market Value Shares Weight %

LLY Eli Lilly & Co 4.81 M 4 639.00 18.08%

Ascendis Pharma A/S 3.85 M 17.01 K 14.45%

ABBV AbbVie Inc 1.94 M 8 680.00 7.27%

UNH UnitedHealth Group Inc 1.17 M 4 066.00 4.38%

PCVX Vaxcyte Inc 1.10 M 20.55 K 4.14%

MASI Masimo Corp 858.86 K 6 254.00 3.23%

LEGN Legend Biotech Corp 846.77 K 48.39 K 3.18%

ISRG Intuitive Surgical Inc 769.94 K 1 527.00 2.89%

NTRA Natera Inc 708.91 K 3 067.00 2.66%

RVMD Revolution Medicines Inc 705.89 K 7 281.00 2.65%

ABVX Abivax SA 687.35 K 6 184.00 2.58%

RYTM Rhythm Pharmaceuticals Inc 658.49 K 6 423.00 2.47%

DHR Danaher Corp 649.67 K 2 968.00 2.44%

ADMA ADMA Biologics Inc 649.53 K 37.55 K 2.44%

COR Cencora Inc 639.05 K 1 779.00 2.40%

GILD Gilead Sciences Inc 607.26 K 4 278.00 2.28%

WGS GeneDx Holdings Corp 570.63 K 5 928.00 2.14%

INSM Insmed Inc 545.75 K 3 479.00 2.05%

BSX Boston Scientific Corp 526.48 K 5 629.00 1.98%

VRTX Vertex Pharmaceuticals Inc 491.05 K 1 045.00 1.85%

1
2

뉴스

2 Best ETFs to Buy in April 2026, According to Analysts - TipRanks.com

Harbor Health Care ETF Q4 2025 Portfolio Review

Eight stock picks to play one of the healthiest corners of the market

Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in

일라이 릴리의 독주: 한 주식이 제약 ETF 전반의 성과를 좌우하는 방법

Opinion: Biotech is back. Here’s why these rallying stocks belong in your portfolio now.

Medistim, 3분기 매출 25.7% 급증, EBIT 27.1% 증가

Medistim Q3 2025 presentation: Revenue surges 25.7% as EBIT climbs 27.1%

메디스팀 2025년 3분기 실적 발표: 견조한 성장세

Earnings call transcript: Medistim’s Q3 2025 results show strong growth

Harbor Health Care ETF Q2 2025 Commentary (NYSEARCA:MEDI)

Time to Buy UnitedHealth-Heavy ETFs?